医院再入院减少计划惩罚对髋膝关节置换再入院的影响:不同惩罚风险医院的比较
研究基于Medicare 2009至2016年Hospital Compare数据,纳入2326家急性护理医院,比较HRRP扩展至择期髋膝关节置换后,不同惩罚风险医院(按Medicare收入占比四分位分组)的30天风险标准化再入院率变化。结果发现,最高惩罚风险组(Q4)再入院率下降18.92%(1.01个百分点),最低惩罚风险组(Q1)下降17.97%(0.98个百分点),组间差异无统计学意义(p=0.45)。结论认为HRRP扩展未导致高惩罚风险医院的再入院率下降幅度更大。
要点
- HRRP扩展至关节置换后,Q4医院再入院率下降18.92%,Q1下降17.97%,差异无统计学意义(p=0.45)。
- 多变量分析中Q4下降18.41%,Q1下降17.35%,组间差异仍无统计学意义(p=0.35)。
- HRRP扩展前后,所有医院再入院率均呈相似速度下降。
核心结论
- HRRP扩展至关节置换未导致高惩罚风险医院的再入院率下降幅度大于低惩罚风险医院。
- 所有医院在HRRP扩展前后再入院率下降速度相似。
研究设计与样本
- 研究使用Medicare 2009至2016年Hospital Compare数据,比较HRRP扩展后(2013年7月至2016年6月)与扩展前(2009年7月至2012年6月)的变化。
- 研究队列包括2326家急性护理医院,以医院总住院收入中Medicare占比四分位代表惩罚风险。
- 主要结局为医院层面关节置换术后30天风险标准化再入院率。
- 采用分层线性回归模型分析HRRP扩展的调整后影响。
主要发现
- 扩展前,Q4医院平均再入院率为5.36%,Q1医院为5.46%。
- HRRP扩展后,Q4医院再入院率下降18.92%(1.01个百分点),Q1医院下降17.97%(0.98个百分点),差异无统计学意义(p=0.45)。
- 多变量分析中,Q4医院下降18.41%(0.98个百分点),Q1医院下降17.35%(0.94个百分点),差异仍无统计学意义(p=0.35)。
临床怎么用
- 再入院和并发症是关节置换手术质量的衡量指标,对患者和提供者有重要的临床和经济意义。
- 本研究检验HRRP等政策干预是否可能减少手术护理中的非预期后果。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the impact of the U.S. Centers for Medicare & Medicaid Services' Hospital Readmissions Reduction Program (HRRP) expansion to include readmissions following elective primary total hip and knee replacements; the expansion was finalized in 2013 and was implemented in 2014. We examined whether hospitals at risk of relatively large penalties from this expansion experienced greater declines in joint replacement readmissions compared with hospitals at risk of smaller penalties. METHODS: We used Medicare's 2009 to 2016 Hospital Compare data sets to examine the impact of the HRRP's expansion in the July 2013 to June 2016 period (post-expansion) compared with the July 2009 to June 2012 period (pre-expansion). The primary outcome was the hospital-level, 30-day, risk-standardized readmission rate (hereafter called the readmission rate) following joint replacement surgical procedures. We used the percentage of a hospital's total inpatient revenue attributed to Medicare (categorized into quartiles) to represent the risk of penalties. We used hierarchical linear regression models to examine the adjusted impact of the HRRP's expansion. RESULTS: Our study cohort included 2,326 acute care hospitals. In the pre-HRRP expansion phase, the mean readmission rate was 5.36% among hospitals with the highest proportion of Medicare revenues (quartile 4) and 5.46% among hospitals with the lowest proportion of Medicare revenues (quartile 1). With the HRRP expansion, the readmission rate declined by 18.92% (1.01 percentage points) among quartile-4 hospitals and by 17.97% (0.98 percentage point) among quartile-1 hospitals (p = 0.45). This nonsignificant difference in readmission rate declines between quartiles persisted in multivariable analysis (a decline of 18.41% [0.98 percentage point] in quartile 4 and a decline of 17.35% [0.94 percentage point] in quartile 1; p = 0.35). CONCLUSIONS: The HRRP's expansion to include joint replacements did not lead to greater reductions in postoperative readmissions among hospitals at risk of larger penalties in comparison with hospitals at risk of smaller penalties. Readmission rates were declining at similar rates among all hospitals, before and after the HRRP's expansion. CLINICAL RELEVANCE: Readmissions and complications following joint replacements are measures of the quality of surgical care. These events have important clinical and economic implications for patients and providers. This study is clinically relevant because it examines whether policy interventions, such as the HRRP, have the potential to reduce these unintended consequences of surgical care.
引用
- Thirukumaran CP, McGarry BE, Glance LG, et al. Impact of Hospital Readmissions Reduction Program Penalties on Hip and Knee Replacement Readmissions: Comparison of Hospitals at Risk of Varying Penalty Amounts. J Bone Joint Surg Am. 2020. PMID: 31613862. doi:10.2106/JBJS.18.01501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。